🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the safety and tolerability of irinotecan liposome in combinat...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-04-08
Trial ID
NCT04796948
Treatments Being Tested
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
This is a randomized, double-blind, active-comparator, parallel-group study...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01730040
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
To evaluate the reduction of low-density lipoprotein cholesterol (LDL-C) by...
Status
Completed
Location
Multiple Locations
Start Date
2012-11-30
Trial ID
NCT01730053
Treatments Being Tested
The purpose of this study is to examine and compare the uptake of levomefol...
Status
Completed
Location
Nuvisan GmbH
Start Date
2006-12
Trial ID
NCT01258660
The goal of this clinical research study is to evaluate the safety and effe...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2014-09
Trial ID
NCT02206425
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as liposome-encapsulated irinot...
Status
Terminated
Location
Hopital Saint Antoine
Start Date
2011-05
Trial ID
NCT01375816
This study is a randomised double blind placebo controlled trial comparing ...
Status
Completed
Location
Alfred Hospital
Start Date
2013-07-02
Trial ID
NCT01813357
Treatments Being Tested
This phase I trial studies side effects of daratumumab, bortezomib, dexamet...
Status
Withdrawn
Location
City of Hope Medical Center
Start Date
2018-10-25
Trial ID
NCT03591744
Treatments Being Tested